Welcome to our dedicated page for COGNEX SEC filings (Ticker: CGNX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Cognex Corporation filings document regulatory disclosures for an operating company focused on industrial machine vision products and automation technology. Its Form 8-K reports cover furnished operating results, quarterly cash dividends, share repurchase authorization, board and officer matters, annual meeting voting results, and changes in the company’s independent registered public accounting firm.
Proxy materials describe director elections, governance matters, executive compensation, shareholder voting procedures, and board committee oversight. The filing record also includes exhibit-based disclosures tied to financial-results releases and capital-return actions involving Cognex common stock.
Cognex Corporation’s Chief Technology Officer, Joerg Kuechen, reported several equity-related transactions. On February 18, 2026, 4,056 restricted stock units were converted into an equal number of common shares at $0.00 per share, and 1,327 of those shares were disposed of at $56.72 per share to cover tax withholding obligations rather than through an open‑market sale. After these transactions, he directly held 2,729 shares of common stock. On February 17, 2026, he also received a direct grant of 8,759 new restricted stock units, which vest 100% on the second anniversary of the grant date. Additional non‑qualified stock options and restricted stock units are listed as existing holdings, reflecting his broader long‑term incentive position.
COGNEX CORP director John Tseng-Chung Lee reported equity compensation activity involving restricted stock units and common shares. On February 18, 2026, he exercised 8,324 restricted stock units for 8,324 shares of common stock at a price of $0.00 per share, bringing his direct common stock holdings to 21,907 shares.
On February 17, 2026, he received a grant of 4,817 restricted stock units, and a separate line shows 2,913 restricted stock units held directly after another transaction. Each restricted stock unit represents the right to receive one share of Cognex common stock, with footnotes indicating these awards vest 100% on the first anniversary of their respective grant dates.
COGNEX CORP director Marjorie Sennett reported equity award activity involving restricted stock units and common shares. On February 18, 2026, restricted stock units covering 8,324 shares were exercised for common stock at $0.0000 per share, leaving 23,023 common shares held directly.
On February 17, 2026, she received a grant of 4,817 restricted stock units, each representing a contingent right to one share of common stock. Footnotes state that certain restricted stock unit awards vest 100% on the first anniversary of their respective grant dates.
COGNEX CORP director Sachin Lawande reported equity awards and an RSU conversion. On February 18, 2026, 8,324 restricted stock units were exercised or converted into 8,324 shares of common stock at a stated price of $0.00 per share, leaving 25,518 common shares held directly.
On February 17, 2026, Lawande received a grant of 4,817 restricted stock units, each representing a contingent right to one share of Cognex common stock. Footnotes state that one RSU grant vests 100% on the first anniversary of the February 18, 2025 grant date, and another vests 100% on the first anniversary of the February 17, 2026 grant date.
COGNEX CORP executive Carl Gerst reported multiple equity award transactions. On February 17, 2026, he received a grant of 24,854 non-qualified stock options and 24,085 restricted stock units (RSUs), each at a price of $0.00 per share.
The options vest in five approximately equal annual installments on the first through fifth anniversaries of the February 17, 2026 grant date. The RSUs granted on that date vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries, respectively. Each RSU represents a contingent right to receive one share of Cognex common stock.
On February 18, 2026, 5,570 RSUs vested and were converted into 5,570 shares of common stock. Of these, 1,766 shares were withheld at $56.72 per share to satisfy tax withholding obligations, leaving 3,804 common shares directly held afterward.
Cognex Corp VP and principal accounting officer Laura Ann Macdonald reported multiple equity transactions. On February 17, 2026, she received a grant of 7,231 non-qualified stock options and 11,211 restricted stock units (RSUs), each RSU representing the contingent right to one common share. The options vest in five approximately equal annual installments beginning on the first anniversary of the grant date, while the RSUs vest 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date.
On February 18, 2026, 2,422 RSUs vested and were converted into the same number of common shares. Of these, 711 shares, valued at $56.72 per share, were withheld to satisfy tax withholding obligations, leaving her with 3,923 directly held common shares and 9,685 RSUs. An additional 20 common shares are held indirectly by her child, for which she disclaims beneficial ownership except to the extent of her pecuniary interest.
Cognex Corporation executive Sheila Marie DiPalma, EVP of Employee Services, reported several equity compensation transactions. On February 17, 2026, she received a grant of 13,557 non-qualified stock options and 13,138 restricted stock units (RSUs), both at a price of $0.00. The options vest in five approximately equal annual installments starting one year after the grant date, while the RSUs vest 20%, 30%, and 50% on the first, second, and third anniversaries.
On February 18, 2026, 3,027 RSUs were exercised and converted into common stock at $0.00, increasing her directly held common shares, and 1,022 common shares at $56.72 were withheld to satisfy tax obligations related to the vesting. After these transactions, she held 8,587 shares of common stock directly and maintained derivative holdings including RSUs and stock options as reported.
COGNEX CORP director Robert Willett reported equity award activity tied to restricted stock units that vested on February 18, 2026. A total of 14,165 restricted stock units were converted into common shares at no cost and are held indirectly by the Willett Parkhill Investment Trust, where he is trustee and beneficiary and disclaims beneficial ownership beyond his economic interest.
To cover tax obligations on this vesting, the trust disposed of 6,849 common shares at $56.72 per share through share withholding rather than an open-market sale. The underlying RSU grant vests in tranches of approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the February 18, 2025 grant date.
Cognex director Anthony Sun reported equity award activity and updated holdings. On February 18, 2026, 8,324 restricted stock units were exercised or converted at an exercise price of $0.00 per unit, resulting in 8,324 shares of common stock and bringing his directly held common stock to 332,172 shares.
On February 17, 2026, Sun received a grant of 4,817 restricted stock units, which each represent a right to one share of Cognex common stock and vest 100% on the first anniversary of the grant date. The filing also lists stock options and common shares held indirectly through Sun Management Associates, LLC, where he disclaims beneficial ownership beyond his pecuniary interest.
Cognex Corporation filed an amended report to update details on its change of independent auditor. The Audit Committee selected KPMG LLP as auditor for the fiscal year ending December 31, 2026, replacing Grant Thornton LLP after Grant Thornton completed its audit of the 2025 financial statements on February 13, 2026.
Grant Thornton’s reports on Cognex’s consolidated financial statements for the years ended December 31, 2025 and 2024 contained no adverse opinions, disclaimers, or qualifications. The company reports no disagreements or reportable events with Grant Thornton and states it did not consult KPMG on specific accounting issues or audit opinions during 2024, 2025, or through February 13, 2026.